Discover how much money can be saved in your clinical trial!

Screen Shot 2018 08 11 at 12.17.32 PM

Subject Registries Reduce Duplicate Subjects Entering CNS Studies

Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations.  Up to 10% in CNS clinical trials and much higher …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Screen Shot 2021 08 06 at 2.24.20 PM

Verified Clinical Trials Partners With The STARR Coalition To Promote Advocacy And Reduce Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …

Read more

Screen Shot 2018 06 27 at 11.15.03 PM

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

Screen Shot 2018 04 19 at 3.41.36 PM

Duplicate Subjects In CNS Clinical Trials and Other Therapeutic Areas Prevented With Verified Clinical Trials Research Subject Database Registry

From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists.  Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality.  Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …

Read more

Characteristics Of Professional Research Subjects and Duplicate Subjects In CNS and Other Clinical Trials Prevented By Verified Clinical Trials

Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data.  The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening.  What we have learned from experience and analytical data review over the …

Read more

Screen Shot 2019 04 23 at 4.01.09 PM

Professional Research Subjects Travel: Prevent Duplicate Subjects In Your Clinical Trials With Verified Clinical Trials

Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues? …

Read more

Screen Shot 2019 04 05 at 3.24.31 PM

Preventing Duplicate Subjects In European Clinical Trials: Average Travel Distance

Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries.  Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of …

Read more